GLP-1 Medication Users to Represent 35% of U.S. Food and Beverage Sales by 2030, New Circana Research Reveals
Chicago, Nov. 18, 2025 (GLOBE NEWSWIRE) — The rapid adoption of GLP-1 medications is fundamentally reshaping U.S. consumer spending habits
Read More